首页> 美国卫生研究院文献>Chronic Respiratory Disease >Cardiovascular risk chronic obstructive pulmonary disease and pulmonary rehabilitation
【2h】

Cardiovascular risk chronic obstructive pulmonary disease and pulmonary rehabilitation

机译:心血管风险慢性阻塞性肺疾病和肺康复

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Patients with chronic obstructive pulmonary disease (COPD) who participate in pulmonary rehabilitation (PR) often have concomitant cardiovascular disease (CVD), which is a frequently undiagnosed and undertreated comorbidity. CVD contributes to the burden of the disease and is associated with an increased risk for hospitalizations and mortality. Optimizing the diagnosis and management of cardiovascular risk and disease should be considered as part of the holistic approach of PR. In addition, we need to consider similarities and differences in cardiac and PR programs, in order to improve personalized care in patients with both diseases. The current review addresses the burden of CVD in COPD patients who participate in PR, how CVD and its risk factors affect PR and should be managed during PR, and extends on what we can learn of the organization of cardiac rehabilitation programs.
机译:参加肺康复(PR)的慢性阻塞性肺疾病(COPD)患者通常伴有心血管疾病(CVD),这是一种经常未被诊断和治疗不足的合并症。 CVD增加了疾病负担,并增加了住院和死亡的风险。优化心血管疾病风险的诊断和管理应被视为PR整体治疗方法的一部分。此外,我们需要考虑心脏和PR程序的异同,以改善两种疾病患者的个性化护理。本篇综述探讨了参与PR的COPD患者的CVD负担,CVD及其危险因素如何影响PR并应在PR期间进行管理,并扩展了我们对心脏康复计划组织的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号